News

Modifying specific proteins during cancer cell division unleashes a natural killing mechanism.

The European Patent Office has announced its intention to grant a broad patent for the revolutionary CRISPR-Cas9 gene-editing technology to the University of California, the University of Vienna and Emmanuelle Charpentier.

A simple colour changing test to help scientists investigate potential cancer drugs has been developed by University of Bath scientists, allowing research to progress at a much greater speed than has been possible until now.

Retrofitted Cryo-EM system solves Samba virus structure

Plasticell signs stem cell research collaborations with leading Singapore academic institutions A*STAR and NTU.

In the new study, researchers have investigated an artificial photocatalyst material using nanoparticles and found out how to make it more efficient.

Chemists have engineered a molecule that re-converts carbon dioxide to carbon monoxide, a carbon neutral fuel source.

£680,000 Innovate UK funding will aid in the development of the Centre for Antimicrobial Pharmacodynamics (CAP) at the University of Liverpool.

New technique can reveal exposure to aflatoxin, a potent carcinogen, before tumors develop.

The immunotherapy demonstrated benefits in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma.